The table below shows NEUROCRINE BIOSCIENCES INC's income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
$2.86B
$2.36B
$1.89B
$1.49B
$1.13B
$1.05B
Cost of revenue
$52.10M
$34.00M
$39.70M
$23.20M
$14.30M
$10.10M
Gross profit
-
-
-
-
-
-
R&D
-
-
-
-
-
-
SG&A
NBIX annual revenue (10-K history)
NEUROCRINE BIOSCIENCES INC reported annual revenue of $2.86B for fiscal year 2025. That is up 21.4% from $2.36B in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $15.00M (FY 2016) to $2.86B. Figures come from the company's audited annual reports as filed with the SEC.
